EPO Patents = 1

Forward Citations = 0

Loading Chart...

33 inventors (with patents filed for the assignee):

Yi Zhang (3 out of 9 patents)

Gaoyong Liao (3 out of 3 patents)

Wei Xiao (2 out of 21 patents)

4. Yanqiu Wang (2 out of 2 patents)

5. Haijian Ding (2 out of 2 patents)

6. Xuehong Dong (2 out of 2 patents)

7. Xiaolian He (2 out of 2 patents)

8. Jian Li (1 out of 235 patents)

9. Shuhui Chen (1 out of 235 patents)

10. Hualiang Jiang (1 out of 44 patents)

11. Jianfei Wang (1 out of 17 patents)

12. Kaixian Chen (1 out of 31 patents)

13. Hai Chen (1 out of 2 patents)

14. Zhenzhong Wang (1 out of 19 patents)

15. Yan Fu (1 out of 14 patents)

7 patents: Sort by Forward Citations

1. 12698336 - Anti-human CD73 monoclonal antibody without hook effect (2026-08-04),

2. 12624080 - Multi-receptor (GLP-1 receptor, GIP receptor, and Gcg receptor) agonist protein (2026-05-12),

3. 12622902 - Anti-arrhythmic pharmaceutical composition and preparation method therefor (2026-05-12),

4. 12590061 - Crystalline form of acetylcholinesterase inhibitor and preparation method therefor and application thereof (2026-03-31),

5. 12570767 - Sequences of anti-ecto-5'-nucleotidase antibodies (2026-03-10),

6. 12565477 - Preparation method for chlorinated compound (2026-03-03),

7. 12558394 - Application of traditional Chinese medicine composition to preparation of medicine for treating or preventing coronavirus infection (2026-02-24),

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#8 in Lianyungang

#3,923 in China

Lianyungang, China

Jiangsu Kanion Pharmaceutical Co., Ltd.

Forward Citations = 0

33 inventors:

Yi Zhang (3 out of 9 patents)

Gaoyong Liao (3 out of 3 patents)

Wei Xiao (2 out of 21 patents)

4. Yanqiu Wang (2 out of 2 patents)

5. Haijian Ding (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Jiangsu Kanion Pharmaceutical Co., Ltd.. Retrieved from https://idiyas.com/company/jiangsu-kanion-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]